Joel A Sincavage

Array ( [id] => 9703897 [patent_doc_number] => 08828959 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-09 [patent_title] => 'Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells' [patent_app_type] => utility [patent_app_number] => 12/050586 [patent_app_country] => US [patent_app_date] => 2008-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 23 [patent_no_of_words] => 6127 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 176 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12050586 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4634496 [patent_doc_number] => 08012947 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-06 [patent_title] => 'Methods and compositions for promoting wound healing' [patent_app_type] => utility [patent_app_number] => 12/047106 [patent_app_country] => US [patent_app_date] => 2008-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 9 [patent_no_of_words] => 16873 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/012/08012947.pdf [firstpage_image] =>[orig_patent_app_number] => 12047106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4711133 [patent_doc_number] => 20080299659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-04 [patent_title] => 'NUCLEIC ACID COMPOUNDS FOR INHIBITING APOB GENE EXPRESSION AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/039668 [patent_app_country] => US [patent_app_date] => 2008-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 37488 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0299/20080299659.pdf [firstpage_image] =>[orig_patent_app_number] => 12039668 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7967161 [patent_doc_number] => 07939652 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-10 [patent_title] => 'Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases' [patent_app_type] => utility [patent_app_number] => 12/072941 [patent_app_country] => US [patent_app_date] => 2008-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17950 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/939/07939652.pdf [firstpage_image] =>[orig_patent_app_number] => 12072941 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4664159 [patent_doc_number] => 20080255066 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'ANTISENSE OLIGONUCLEOTIDE STRATEGIES FOR THE ENHANCEMENT OF CANCER THERAPIES' [patent_app_type] => utility [patent_app_number] => 12/029297 [patent_app_country] => US [patent_app_date] => 2008-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 22465 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20080255066.pdf [firstpage_image] =>[orig_patent_app_number] => 12029297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5336681 [patent_doc_number] => 20090053145 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'ANTI-VIRAL COMPOSITIONS AND METHODS OF USE IN CATTLE' [patent_app_type] => utility [patent_app_number] => 12/020992 [patent_app_country] => US [patent_app_date] => 2008-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 13329 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20090053145.pdf [firstpage_image] =>[orig_patent_app_number] => 12020992 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 122173 [patent_doc_number] => 07709630 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-04 [patent_title] => 'Antisense modulation of connective tissue growth factor expression' [patent_app_type] => utility [patent_app_number] => 12/011761 [patent_app_country] => US [patent_app_date] => 2008-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33170 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/709/07709630.pdf [firstpage_image] =>[orig_patent_app_number] => 12011761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4927902 [patent_doc_number] => 20080167265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-10 [patent_title] => 'MODULATION OF FR-ALPHA EXPRESSION' [patent_app_type] => utility [patent_app_number] => 11/971027 [patent_app_country] => US [patent_app_date] => 2008-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21591 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20080167265.pdf [firstpage_image] =>[orig_patent_app_number] => 11971027 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6321804 [patent_doc_number] => 20100113559 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'Chitosan Based Polymer Conjugate and a Method for Producing the Same' [patent_app_type] => utility [patent_app_number] => 12/522215 [patent_app_country] => US [patent_app_date] => 2008-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 17592 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113559.pdf [firstpage_image] =>[orig_patent_app_number] => 12522215 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4720106 [patent_doc_number] => 20080242629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'ANTISENSE MODULATION OF APOLIPOPROTEIN B EXPRESSION' [patent_app_type] => utility [patent_app_number] => 11/969096 [patent_app_country] => US [patent_app_date] => 2008-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29594 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20080242629.pdf [firstpage_image] =>[orig_patent_app_number] => 11969096 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4720106 [patent_doc_number] => 20080242629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'ANTISENSE MODULATION OF APOLIPOPROTEIN B EXPRESSION' [patent_app_type] => utility [patent_app_number] => 11/969096 [patent_app_country] => US [patent_app_date] => 2008-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29594 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20080242629.pdf [firstpage_image] =>[orig_patent_app_number] => 11969096 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4720106 [patent_doc_number] => 20080242629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'ANTISENSE MODULATION OF APOLIPOPROTEIN B EXPRESSION' [patent_app_type] => utility [patent_app_number] => 11/969096 [patent_app_country] => US [patent_app_date] => 2008-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29594 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20080242629.pdf [firstpage_image] =>[orig_patent_app_number] => 11969096 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5436212 [patent_doc_number] => 20090170799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'MODULATION OF C-REACTIVE PROTEIN EXPRESSION' [patent_app_type] => utility [patent_app_number] => 11/969208 [patent_app_country] => US [patent_app_date] => 2008-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49343 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170799.pdf [firstpage_image] =>[orig_patent_app_number] => 11969208 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4720106 [patent_doc_number] => 20080242629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'ANTISENSE MODULATION OF APOLIPOPROTEIN B EXPRESSION' [patent_app_type] => utility [patent_app_number] => 11/969096 [patent_app_country] => US [patent_app_date] => 2008-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29594 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20080242629.pdf [firstpage_image] =>[orig_patent_app_number] => 11969096 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4792683 [patent_doc_number] => 20080293657 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'MODULATION OF THE EXPRESSION OF STAT-1-DEPENDENT GENES' [patent_app_type] => utility [patent_app_number] => 11/961574 [patent_app_country] => US [patent_app_date] => 2007-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11214 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20080293657.pdf [firstpage_image] =>[orig_patent_app_number] => 11961574 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7550690 [patent_doc_number] => 08063023 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-22 [patent_title] => 'Impaired wound healing compositions and treatments' [patent_app_type] => utility [patent_app_number] => 12/001498 [patent_app_country] => US [patent_app_date] => 2007-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 22028 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/063/08063023.pdf [firstpage_image] =>[orig_patent_app_number] => 12001498 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5587650 [patent_doc_number] => 20090106852 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'Influenza Therapeutic' [patent_app_type] => utility [patent_app_number] => 11/952056 [patent_app_country] => US [patent_app_date] => 2007-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 57 [patent_figures_cnt] => 57 [patent_no_of_words] => 61576 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20090106852.pdf [firstpage_image] =>[orig_patent_app_number] => 11952056 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6368018 [patent_doc_number] => 20100074897 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'Methods and Compositions related to HIF-1 alpha' [patent_app_type] => utility [patent_app_number] => 12/517132 [patent_app_country] => US [patent_app_date] => 2007-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 48563 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20100074897.pdf [firstpage_image] =>[orig_patent_app_number] => 12517132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6588687 [patent_doc_number] => 20100061989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'METHOD OF TREATMENT AND PROPHYLAXIS' [patent_app_type] => utility [patent_app_number] => 12/515942 [patent_app_country] => US [patent_app_date] => 2007-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15458 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20100061989.pdf [firstpage_image] =>[orig_patent_app_number] => 12515942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4676856 [patent_doc_number] => 20080214487 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents' [patent_app_type] => utility [patent_app_number] => 11/986471 [patent_app_country] => US [patent_app_date] => 2007-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 26028 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20080214487.pdf [firstpage_image] =>[orig_patent_app_number] => 11986471 [rel_patent_id] =>[rel_patent_doc_number] =>)